Cureseq
Brisbane, California, United States
About Cureseq
CureSeq’s mission is to revolutionize next-generation sequencing in the oncology space by making it more affordable, offering faster time to results with a comprehensive solution. They offer products to advance your research endeavors, and will open their services shortly. Turnaround time using their products is 48 hours from extraction through generating clinically relevant mutations. CureSeq’s technology is born out of the Applied Genomics Thoracic Oncology Lab of Dr. Il-Jin Kim at UCSF.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $700.0K
- Last round: Series Unknown (Aug 2016)
- Website: cureseq.com
- Phone: 4158595468
Industries & Categories
Bioinformatics, Biotechnology, Genetics, Oncology
Social Profiles
Canonical: https://fsome.com/organization/cureseq-2506926 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.